Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Sep 1;100(5):1028–1036. doi: 10.1172/JCI119613

Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.

V Rosti 1, G Tremml 1, V Soares 1, P P Pandolfi 1, L Luzzatto 1, M Bessler 1
PMCID: PMC508277  PMID: 9276719

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) develops in patients who have had a somatic mutation in the X-linked PIG-A gene in a hematopoietic stem cell; as a result, a proportion of blood cells are deficient in all glycosyl phosphatidylinositol (GPI)-anchored proteins. Although the PIG-A mutation explains the phenotype of PNH cells, the mechanism enabling the PNH stem cell to expand is not clear. To examine this growth behavior, and to investigate the role of GPI-linked proteins in hematopoietic differentiation, we have inactivated the pig-a gene by homologous recombination in mouse embryonic stem (ES) cells. In mouse chimeras, pig-a- ES cells were able to contribute to hematopoiesis and to differentiate into mature red cells, granulocytes, and lymphocytes with the PNH phenotype. The proportion of PNH red cells was substantial in the fetus, but decreased rapidly after birth. Likewise, PNH granulocytes could only be demonstrated in the young mouse. In contrast, the percentage of lymphocytes deficient in GPI-linked proteins was more stable. In vitro, pig-a- ES cells were able to form pig-a- embryoid bodies and to undergo hematopoietic (erythroid and myeloid) differentiation. The number and the percentage of pig-a- embryoid bodies with hematopoietic differentiation, however, were significantly lower when compared with wild-type embryoid bodies. Our findings demonstrate that murine ES cells with a nonfunctional pig-a gene are competent for hematopoiesis, and give rise to blood cells with the PNH phenotype. pig-a inactivation on its own, however, does not confer a proliferative advantage to the hematopoietic stem cell. This provides direct evidence for the notion that some additional factor(s) are needed for the expansion of the mutant clone in patients with PNH.

Full Text

The Full Text of this article is available as a PDF (278.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bessler M., Hillmen P., Longo L., Luzzatto L., Mason P. J. Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21. Hum Mol Genet. 1994 May;3(5):751–757. doi: 10.1093/hmg/3.5.751. [DOI] [PubMed] [Google Scholar]
  2. Bessler M., Mason P. J., Hillmen P., Miyata T., Yamada N., Takeda J., Luzzatto L., Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J. 1994 Jan 1;13(1):110–117. doi: 10.1002/j.1460-2075.1994.tb06240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bessler M., Mason P., Hillmen P., Luzzatto L. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet. 1994 Apr 16;343(8903):951–953. doi: 10.1016/s0140-6736(94)90068-x. [DOI] [PubMed] [Google Scholar]
  4. Bielinska M., Narita N., Heikinheimo M., Porter S. B., Wilson D. B. Erythropoiesis and vasculogenesis in embryoid bodies lacking visceral yolk sac endoderm. Blood. 1996 Nov 15;88(10):3720–3730. [PubMed] [Google Scholar]
  5. Brunner G., Gabrilove J., Rifkin D. B., Wilson E. L. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J Cell Biol. 1991 Sep;114(6):1275–1283. doi: 10.1083/jcb.114.6.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dacie J. V., Lewis S. M. Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol. 1972;5(3):3–23. [PubMed] [Google Scholar]
  7. Dameshek W. Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and "hypoplastic" leukemia have in common? Blood. 1967 Aug;30(2):251–254. [PubMed] [Google Scholar]
  8. Doetschman T. C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985 Jun;87:27–45. [PubMed] [Google Scholar]
  9. Dunn D. E., Yu J., Nagarajan S., Devetten M., Weichold F. F., Medof M. E., Young N. S., Liu J. M. A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7938–7943. doi: 10.1073/pnas.93.15.7938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gordon M. Y., Lewis J. L., Marley S. B., Grand F. H., Goldman J. M. Stromal cells negatively regulate primitive haemopoietic progenitor cell activation via a phosphatidylinositol-anchored cell adhesion/signalling mechanism. Br J Haematol. 1997 Mar;96(3):647–653. [PubMed] [Google Scholar]
  11. Gordon M. Y., Riley G. P., Watt S. M., Greaves M. F. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. 1987 Mar 26-Apr 1Nature. 326(6111):403–405. doi: 10.1038/326403a0. [DOI] [PubMed] [Google Scholar]
  12. Hillmen P., Lewis S. M., Bessler M., Luzzatto L., Dacie J. V. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995 Nov 9;333(19):1253–1258. doi: 10.1056/NEJM199511093331904. [DOI] [PubMed] [Google Scholar]
  13. HogenEsch H., Gijbels M. J., Offerman E., van Hooft J., van Bekkum D. W., Zurcher C. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol. 1993 Sep;143(3):972–982. [PMC free article] [PubMed] [Google Scholar]
  14. Kawagoe K., Kitamura D., Okabe M., Taniuchi I., Ikawa M., Watanabe T., Kinoshita T., Takeda J. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood. 1996 May 1;87(9):3600–3606. [PubMed] [Google Scholar]
  15. Kawagoe K., Takeda J., Endo Y., Kinoshita T. Molecular cloning of murine pig-a, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus. Genomics. 1994 Oct;23(3):566–574. doi: 10.1006/geno.1994.1544. [DOI] [PubMed] [Google Scholar]
  16. Kinoshita T., Inoue N., Takeda J. Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria. Adv Immunol. 1995;60:57–103. doi: 10.1016/s0065-2776(08)60584-2. [DOI] [PubMed] [Google Scholar]
  17. Laird P. W., Zijderveld A., Linders K., Rudnicki M. A., Jaenisch R., Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 1991 Aug 11;19(15):4293–4293. doi: 10.1093/nar/19.15.4293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lewis S. M., Dacie J. V. The aplastic anaemia--paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol. 1967 Mar;13(2):236–251. doi: 10.1111/j.1365-2141.1967.tb08736.x. [DOI] [PubMed] [Google Scholar]
  19. Luzzatto L., Bessler M., Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell. 1997 Jan 10;88(1):1–4. doi: 10.1016/s0092-8674(00)81850-4. [DOI] [PubMed] [Google Scholar]
  20. Luzzatto L., Bessler M. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol. 1996 Mar;3(2):101–110. doi: 10.1097/00062752-199603020-00001. [DOI] [PubMed] [Google Scholar]
  21. Masterson W. J., Doering T. L., Hart G. W., Englund P. T. A novel pathway for glycan assembly: biosynthesis of the glycosyl-phosphatidylinositol anchor of the trypanosome variant surface glycoprotein. Cell. 1989 Mar 10;56(5):793–800. doi: 10.1016/0092-8674(89)90684-3. [DOI] [PubMed] [Google Scholar]
  22. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 1996 Sep 20;86(6):897–906. doi: 10.1016/s0092-8674(00)80165-8. [DOI] [PubMed] [Google Scholar]
  23. Moore M. A., Metcalf D. Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol. 1970 Mar;18(3):279–296. doi: 10.1111/j.1365-2141.1970.tb01443.x. [DOI] [PubMed] [Google Scholar]
  24. Pevny L., Lin C. S., D'Agati V., Simon M. C., Orkin S. H., Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development. 1995 Jan;121(1):163–172. doi: 10.1242/dev.121.1.163. [DOI] [PubMed] [Google Scholar]
  25. Roberts R., Gallagher J., Spooncer E., Allen T. D., Bloomfield F., Dexter T. M. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature. 1988 Mar 24;332(6162):376–378. doi: 10.1038/332376a0. [DOI] [PubMed] [Google Scholar]
  26. Rosse W. F., Dacie J. V. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest. 1966 May;45(5):736–748. doi: 10.1172/JCI105388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rosse W. F. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood. 1990 Apr 15;75(8):1595–1601. [PubMed] [Google Scholar]
  28. Rosse W. F., Ware R. E. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood. 1995 Nov 1;86(9):3277–3286. [PubMed] [Google Scholar]
  29. Rotoli B., Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Baillieres Clin Haematol. 1989 Jan;2(1):113–138. doi: 10.1016/s0950-3536(89)80010-1. [DOI] [PubMed] [Google Scholar]
  30. Stowe H. D., Wagner J. L., Pick J. R. A debilitating fatal murine dermatitis. Lab Anim Sci. 1971 Dec;21(6):892–897. [PubMed] [Google Scholar]
  31. Swiatek P. J., Gridley T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev. 1993 Nov;7(11):2071–2084. doi: 10.1101/gad.7.11.2071. [DOI] [PubMed] [Google Scholar]
  32. Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T., Takahashi M., Kitani T., Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993 May 21;73(4):703–711. doi: 10.1016/0092-8674(93)90250-t. [DOI] [PubMed] [Google Scholar]
  33. Watanabe R., Kinoshita T., Masaki R., Yamamoto A., Takeda J., Inoue N. PIG-A and PIG-H, which participate in glycosylphosphatidylinositol anchor biosynthesis, form a protein complex in the endoplasmic reticulum. J Biol Chem. 1996 Oct 25;271(43):26868–26875. doi: 10.1074/jbc.271.43.26868. [DOI] [PubMed] [Google Scholar]
  34. Wiles M. V. Embryonic stem cell differentiation in vitro. Methods Enzymol. 1993;225:900–918. doi: 10.1016/0076-6879(93)25057-9. [DOI] [PubMed] [Google Scholar]
  35. Wiles M. V., Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development. 1991 Feb;111(2):259–267. doi: 10.1242/dev.111.2.259. [DOI] [PubMed] [Google Scholar]
  36. van Kamp H., Landegent J. E., Jansen R. P., Willemze R., Fibbe W. E. Clonal hematopoiesis in patients with acquired aplastic anemia. Blood. 1991 Dec 15;78(12):3209–3214. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES